DOLIVER ADVISORS, LP – CRISPR Therapeutics AG Transaction History
DOLIVER ADVISORS, LP portfolio value:
$201,000
portfolio value
DOLIVER ADVISORS, LP quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -30.20% | -1.33K shares | -67K | $65.35 | 3.08K |
| Q2 2022 | share | Decrease | -12.64% | -639 shares | -49K | $60.77 | 4.41K |
| Q1 2022 | share | Decrease | -0.02% | -1 shares | 4K | $62.77 | 5.05K |
| Q4 2021 | share | Increase | +34.64% | 1.30K shares | -107K | $78.85 | 5.05K |
| Q3 2021 | share | Increase | +34.43% | 962 shares | -32K | $111.93 | 3.75K |
| Q2 2021 | share | Decrease | -21.30% | -756 shares | 19K | $161.89 | 2.79K |
| Q1 2021 | share | Increase | 0.00% | 3.55K shares | 433K | $121.85 | 3.55K |